Cargando…

Identification of Cancer-Specific Methylation of Gene Combination for the Diagnosis of Bladder Cancer

Here we conducted an evidence-based study in developing and validating a urinary biomarker combination of gene methylation assays in patients with hematuria. A number of 99 urine samples were obtained and detected from Chinese patients with hematuria. The Cancer Genome Atlas cohort with methylation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ning, Chen, Siteng, Wu, Lingfeng, Wu, Yishuo, Jiang, Guangliang, Shao, Jialiang, Chen, Lixin, Sun, Jishan, Na, Rong, Wang, Xiang, Xu, Jianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856882/ https://www.ncbi.nlm.nih.gov/pubmed/31777606 http://dx.doi.org/10.7150/jca.28192

Ejemplares similares

The study on copy number alteration of clear cell renal cancer in Chinese population
por: Zhang, Ning, et al.
Publicado: (2020)

A novel gene signature combination improves the prediction of overall survival in urinary bladder cancer
por: Chen, Siteng, et al.
Publicado: (2019)

Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinoma
por: Chen, Siteng, et al.
Publicado: (2022)

Clinical use of machine learning‐based pathomics signature for diagnosis and survival prediction of bladder cancer
por: Chen, Siteng, et al.
Publicado: (2021)

The Clinical Implications and Molecular Mechanism of CX3CL1 Expression in Urothelial Bladder Cancer
por: Jiang, Guangliang, et al.
Publicado: (2021)

Prediction of Bacillus Calmette-Guerin Response in Patients with Bladder Cancer after Transurethral Resection of Bladder Tumor by Using Genetic Variation Based on Genomic Studies
por: Zhang, Ning, et al.
Publicado: (2016)

Multi-omics Perspective on the Tumor Microenvironment based on PD-L1 and CD8 T-Cell Infiltration in Urothelial Cancer
por: Chen, Siteng, et al.
Publicado: (2019)

The effect of discrepancy between radiologic size and pathologic tumor size in renal cell cancer
por: Zhang, Ning, et al.
Publicado: (2016)

Genome‐Wide 3′‐UTR Single Nucleotide Polymorphism Association Study Identifies Significant Prostate Cancer Risk‐Associated Functional Loci at 8p21.2 in Chinese Population
por: Zhang, Ning, et al.
Publicado: (2022)

The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population
por: Liu, Shenghua, et al.
Publicado: (2015)

Genome-wide Association Study (GWAS) of Germline Copy Number Variations (CNVs) Reveal Genetic Risks of Prostate Cancer in Chinese population
por: Wu, Yishuo, et al.
Publicado: (2018)

Animal models for bladder cancer: The model establishment and evaluation (Review)
por: ZHANG, NING, et al.
Publicado: (2015)

Identification of adenylate cyclase 2 methylation in bladder cancer with implications for prognosis and immunosuppressive microenvironment
por: Yang, Jianfeng, et al.
Publicado: (2022)

DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups
por: Tian, Zijian, et al.
Publicado: (2020)

Plasma genistein and risk of prostate cancer in Chinese population
por: Wu, Yishuo, et al.
Publicado: (2015)

Clinically available RNA profiling tests of prostate tumors: utility and comparison
por: Na, Rong, et al.
Publicado: (2016)

Genetic risk scores based on risk-associated single nucleotide polymorphisms can reveal inherited risk of bladder cancer in Chinese population
por: Xu, Chenyang, et al.
Publicado: (2020)

A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma
por: Chen, Siteng, et al.
Publicado: (2022)

Age-Specific Prostate Specific Antigen Cutoffs for Guiding Biopsy Decision in Chinese Population
por: Na, Rong, et al.
Publicado: (2013)

A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer Patients
por: Chen, Siteng, et al.
Publicado: (2021)

Identification of potential DNA methylation biomarkers related to diagnosis in patients with bladder cancer through integrated bioinformatic analysis
por: Cheng, Hongxia, et al.
Publicado: (2023)

A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients
por: Huang, Hai, et al.
Publicado: (2023)

miR-145-5p: A Potential Biomarker in Predicting Gleason Upgrading of Prostate Biopsy Samples Scored 3+3=6
por: Wang, Tao, et al.
Publicado: (2021)

Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011
por: Na, Rong, et al.
Publicado: (2012)

Identification of Methylated Genes Associated with Aggressive Bladder Cancer
por: Marsit, Carmen J., et al.
Publicado: (2010)

Coexistence of YWHAZ amplification predicts better prognosis in muscle-invasive bladder cancer with CDKN2A or TP53 loss
por: Liu, Shenghua, et al.
Publicado: (2016)

Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
por: Huang, Da, et al.
Publicado: (2020)

The feasibility of proteomics sequencing based immune-related prognostic signature for predicting clinical outcomes of bladder cancer patients
por: Jiang, Liren, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNAs signature predicts prognosis in bladder cancer
por: Wu, Lingfeng, et al.
Publicado: (2023)

Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer
por: Wu, Xiang, et al.
Publicado: (2019)

Genetic scores based on risk-associated single nucleotide polymorphisms (SNPs) can reveal inherited risk of renal cell carcinoma
por: Wu, Yishuo, et al.
Publicado: (2016)

Advances in Diagnosis and Therapy for Bladder Cancer
por: Hu, Xinzi, et al.
Publicado: (2022)

Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile
por: Zhang, Shumei, et al.
Publicado: (2022)

Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder Cancer
por: Reinert, Thomas
Publicado: (2012)

lncRNA-UCA1 in the diagnosis of bladder cancer: A meta-analysis
por: Ding, Zhenshan, et al.
Publicado: (2021)

Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA
por: Oh, Tae Jeong, et al.
Publicado: (2022)

Prognostic significance of SNCA and its methylation in bladder cancer
por: Wu, Zhengcun, et al.
Publicado: (2022)

A Systematic Analysis on DNA Methylation and the Expression of Both mRNA and microRNA in Bladder Cancer
por: Zhu, Jialou, et al.
Publicado: (2011)

Germline genetic variations in PDZD2 and ITPR2 genes are associated with clear cell renal cell carcinoma in Chinese population
por: Zhang, Ning, et al.
Publicado: (2016)

Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer
por: Zhao, Zihan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4lm4eh7klkq85urdn3h9uc8086